Transactions classified within the Pharmaceuticals sub-sector. Sectors follow a structured hierarchy so filters and comparable sets stay reproducible.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| OPHAM | CFAO Healthcare | Pharmaceuticals Wholesale | $10.2M – $13.8M | 5× – 7× | |
| Laboratoires Herbolistique | Yotta, Ouest Croissance | Alternative Medicine | $18.0M – $24.4M | 7× – 9× | |
| Nordic Group bv | Alfasigma spa | Proprietary & Advanced Pharmaceuticals | $431M – $583M | 10× – 14× | |
| SimoTech | PerkinElmer | Pharmaceuticals (NEC) | $52.0M – $70.0M | 10× – 13× | |
| Raghava Life Sciences API and intermediates business | RPG Active Pharma | Generic Pharmaceuticals | $18.1M | 5× – 7× | |
| Holistic Health | Yellow Wood Partners | Alternative Medicine | $1,000M | 4× – 5× | |
| Weigao Puri | Weigao Blood Purification | Pharmaceuticals (NEC) | $355M – $480M | 10× – 13× | |
| Recordati | Respighi BidCo spa, CVC Capital Partners Fund IX, Groupe Bruxelles Lambert (GBL), Abu Dhabi Investment Authority (ADIA), CPP Investments, MGG Strategic SICAF SIF, CapSol, PSP Investments, StepStone, AlpInvest, Andrea Recordati | Proprietary & Advanced Pharmaceuticals | $11,612M | 13.8× | |
| Thorne | Procter & Gamble | Alternative Medicine | $3,800M | 16× – 21× | |
| BioXcel Therapeutics Inc. | Teva Pharmaceuticals International GmbH | Proprietary & Advanced Pharmaceuticals | $4.2M – $5.8M | 3× – 3× |
Bins are observed deal frequencies across disclosed transactions. Use as a directional reference, not a target valuation.
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.